vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $31.5M, roughly 1.2× Community Healthcare Trust Inc). On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (4.8% vs -57.1%). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (7.0% CAGR vs -46.5%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
CHCT vs ORGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $37.2M |
| Net Profit | $2.5M | — |
| Gross Margin | — | 30.8% |
| Operating Margin | — | -185.1% |
| Net Margin | 8.1% | — |
| Revenue YoY | 4.8% | -57.1% |
| Net Profit YoY | 60.2% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | $37.2M | ||
| Q4 25 | $30.9M | $225.6M | ||
| Q3 25 | $31.1M | $150.9M | ||
| Q2 25 | $29.1M | $101.0M | ||
| Q1 25 | $30.1M | $86.7M | ||
| Q4 24 | $29.3M | $126.7M | ||
| Q3 24 | $29.6M | $115.2M | ||
| Q2 24 | $27.5M | $130.2M |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | $43.7M | ||
| Q3 25 | $1.6M | $21.6M | ||
| Q2 25 | $-12.6M | $-9.4M | ||
| Q1 25 | $1.6M | $-18.8M | ||
| Q4 24 | $1.8M | $7.7M | ||
| Q3 24 | $1.7M | $12.3M | ||
| Q2 24 | $-10.4M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | — | 28.1% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | — | -12.5% | ||
| Q1 25 | — | -30.9% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | — | -10.7% |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | 19.4% | ||
| Q3 25 | 5.3% | 14.3% | ||
| Q2 25 | -43.2% | -9.3% | ||
| Q1 25 | 5.3% | -21.7% | ||
| Q4 24 | 6.3% | 6.1% | ||
| Q3 24 | 5.9% | 10.7% | ||
| Q2 24 | -37.9% | -13.1% |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | $0.31 | ||
| Q3 25 | $0.03 | $0.11 | ||
| Q2 25 | $-0.50 | $-0.10 | ||
| Q1 25 | $0.03 | $-0.17 | ||
| Q4 24 | $0.04 | $0.05 | ||
| Q3 24 | $0.04 | $0.09 | ||
| Q2 24 | $-0.42 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $91.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $421.3M | — |
| Total Assets | $1.0B | $520.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | $91.4M | ||
| Q4 25 | $3.3M | $93.7M | ||
| Q3 25 | $3.4M | $63.7M | ||
| Q2 25 | $4.9M | $73.1M | ||
| Q1 25 | $2.3M | $110.0M | ||
| Q4 24 | $4.4M | $135.6M | ||
| Q3 24 | $2.8M | $94.3M | ||
| Q2 24 | $734.0K | $89.9M |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | — | ||
| Q4 24 | $486.0M | — | ||
| Q3 24 | $473.7M | $62.3M | ||
| Q2 24 | $457.6M | $63.8M |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | $300.1M | ||
| Q3 25 | $426.8M | $255.1M | ||
| Q2 25 | $437.8M | $233.2M | ||
| Q1 25 | $461.3M | $242.9M | ||
| Q4 24 | $476.0M | $262.9M | ||
| Q3 24 | $477.2M | $278.5M | ||
| Q2 24 | $497.8M | $263.5M |
| Q1 26 | $1.0B | $520.0M | ||
| Q4 25 | $990.8M | $598.7M | ||
| Q3 25 | $987.3M | $509.8M | ||
| Q2 25 | $966.3M | $461.1M | ||
| Q1 25 | $985.1M | $467.4M | ||
| Q4 24 | $992.6M | $497.9M | ||
| Q3 24 | $981.8M | $446.3M | ||
| Q2 24 | $983.2M | $443.2M |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | 0.22× | ||
| Q2 24 | 0.92× | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
